Abstract

A simple and rapid method for the absorption rate calculation for drugs exhibiting linear pharmacokinetics is proposed. The method employs the novel instantaneous midpoint-input principle, which assumes that all drug absorbed during a given interval, regardless of the complexity of the absorption kinetics, is absorbed instantaneously at the midpoint of the interval. The drug amount absorbed is calculated by comparing the net plasma level resulting from the absorption during that interval with the plasma drug level obtained after intravenous dosing at the midpoint of the absorption interval. The method does not assume any compartments or models commonly used in pharmacokinetic studies. In examples with markedly different pharmacokinetic properties, the new method yielded accurate results almost identical to those obtained with the standard Wagner-Nelson and Loo-Riegelman methods. The method often is accurate to two to four significant figures in absorption rate calculations. For first-order absorption, the new method appears to be less subject to the influence of timing of the first blood sample. Theoretically, information on only a small portion of the intravenous plasma level-time profile is sufficient for the analysis. Data on plasma levels shortly after intravenous dosing and the terminal biological half-life are not always needed. Thus, the method might be particularly useful for drugs with long or uncertain biological half-lives. Theoretically, the method also can be applied to urine or saliva data. The method assumes the same drug disposition kinetics between the intravenous and absorption studies.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.